RGS4 polymorphism and response to electroconvulsive therapy in major depressive disorder

被引:13
|
作者
Huuhka, Kaija [1 ,2 ]
Kampman, Olli [1 ,3 ]
Anttila, Sami [1 ,4 ]
Huuhka, Martti [1 ,2 ]
Rontu, Riikka [1 ,4 ]
Mattila, Kari M. [1 ,4 ]
Hurme, Mikko [1 ,4 ]
Lehtimaki, Terho [1 ,4 ]
Leinonen, Esa [1 ,2 ]
机构
[1] Univ Tampere, Sch Med, Tampere 33014, Finland
[2] Tampere Univ Hosp, Dept Psychiat, Pitkaniemi 33380, Finland
[3] Seinajoki Hosp Dist, Dept Psychiat, Seinajoki, Finland
[4] Tampere Univ Hosp, Dept Clin Chem, Lab Atherosclerosis Genet, Ctr Lab Med, FIN-33521 Tampere, Finland
关键词
RGS4; major depression; electroconvulsive therapy;
D O I
10.1016/j.neulet.2008.03.065
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
We studied the association between RGS4 (rs951436) polymorphism and treatment response in electroconvulsive therapy (ECT) as well as risk of treatment-resistant depression. The study sample consisted of 119 patients with major depressive disorder (MDD) and 384 healthy control subjects. RGS4 polymorphism was not associated with treatment response in ECT or risk of MDD. According to the present data, the impact of RGS4 genotype is not decisive in major depressive disorder. The results provide preliminary data on the impact of RGS4 polymorphism in treatment response in ECT. (C) 2008 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:25 / 28
页数:4
相关论文
共 50 条
  • [1] The apolipoprotein E polymorphism is not associated with response to electroconvulsive therapy in major depressive disorder
    Huuhka, M
    Anttila, S
    Leinonen, E
    Huuhka, K
    Rontu, R
    Mattila, KM
    Huhtala, H
    Lehtimäki, T
    JOURNAL OF ECT, 2005, 21 (01) : 7 - 11
  • [2] PREDICTORS OF RESPONSE TO ELECTROCONVULSIVE-THERAPY IN MAJOR DEPRESSIVE DISORDER
    PANDE, AC
    KRUGLER, T
    HASKETT, RF
    GREDEN, JF
    GRUNHAUS, LJ
    BIOLOGICAL PSYCHIATRY, 1988, 24 (01) : 91 - 93
  • [3] Influence of episode duration of major depressive disorder on response to electroconvulsive therapy
    Pluijms, EM
    Birkenhäger, TK
    Mulder, PG
    van den Broek, WW
    JOURNAL OF AFFECTIVE DISORDERS, 2006, 90 (2-3) : 233 - 237
  • [4] Analysis of the association of MIR124-1 and its target gene RGS4 polymorphisms with major depressive disorder and antidepressant response
    Zeng, Duan
    He, Shen
    Yu, Shunying
    Li, Guanjun
    Ma, Changlin
    Wen, Yi
    Shen, Yifeng
    Yu, Yimin
    Li, Huafang
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2018, 14 : 715 - 723
  • [5] Predicting efficacy of electroconvulsive therapy in major depressive disorder
    Tsuchiyama, K
    Nagayama, H
    Yamada, K
    Isogawa, K
    Katsuragi, S
    Kiyota, A
    PSYCHIATRY AND CLINICAL NEUROSCIENCES, 2005, 59 (05) : 546 - 550
  • [6] Thalamocortical connectivity in electroconvulsive therapy for major depressive disorder
    Wei, Qiang
    Bai, Tongjian
    Brown, Elliot C.
    Xie, Wen
    Chen, Yang
    Ji, Gongjun
    Ramasubbu, Rajamannar
    Tian, Yanghua
    Wang, Kai
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 264 : 163 - 171
  • [7] Predictors of Electroconvulsive Therapy Outcome in Major Depressive Disorder
    Su, Liang
    Zhang, Yi
    Jia, Yuping
    Sun, Junfeng
    Mellor, David
    Yuan, Ti-Fei
    Xu, Yifeng
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2023, 26 (01): : 53 - 60
  • [8] Benefits of Electroconvulsive Therapy for Patients With Major Depressive Disorder
    Gaynes, Bradley N.
    JAMA NETWORK OPEN, 2021, 4 (07)
  • [9] Seizure Duration and Electroconvulsive Therapy in Major Depressive Disorder
    Gillving, Cecilia
    Ekman, Carl Johan
    Hammar, Asa
    Landen, Mikael
    Lundberg, Johan
    Rad, Pouya Movahed
    Nordanskog, Pia
    von Knorring, Lars
    Nordenskjold, Axel
    JAMA NETWORK OPEN, 2024, 7 (07)
  • [10] Speed of antidepressant response to electroconvulsive therapy in bipolar disorder vs. major depressive disorder
    Agarkar, Smita
    Hurt, Stephen W.
    Young, Robert C.
    PSYCHIATRY RESEARCH, 2018, 265 : 355 - 359